Second, we identify targets that interact with and modulate the transcriptional activity of HEY1, including the proposed upstream methyltransferase DNMT1 responsible for epigenetic control, and downstream mutant p53, which may contribute to cancer phenotypes in GBM. This evidence concerns the gene TP53 and cancer.